From engineering AAV sequences to large scale manufacturing: a reliable and scalable GMP transferable process using Sf9 cell system

10/25/2022

sponsored by Cytiva

October 25, 2022 - 17:00 CEST

Learn about Cytiva's catalogue of ready-to-use engineered AAVrep/cap sequences. And we are developing a robust and scalable adeno-associated virus (AAV) manufacturing process in Sf9 cell lines using novel fiber-based affinity technology with the potential to scale from PD to manufacturing.

Webinar Learning Objectives:

AAV Manufacturing using SF9 cell lines
High yield downstream process optimization GMP ready
Learn how Cytia can support your Gene Therapy project

Visit our Webinar Hub

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.